Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
268.46
-2.56 (-0.94%)
At close: Mar 28, 2025, 4:00 PM
266.00
-2.46 (-0.92%)
After-hours: Mar 28, 2025, 7:58 PM EDT
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Strong Buy
Price Target
$319.27
Upside
+18.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold → Buy Upgrades $280 → $328 | Hold → Buy | Upgrades | $280 → $328 | +22.18% | Mar 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $338 → $351 | Strong Buy | Maintains | $338 → $351 | +30.75% | Mar 21, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $385 → $390 | Strong Buy | Maintains | $385 → $390 | +45.27% | Mar 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $310 → $330 | Buy | Maintains | $310 → $330 | +22.92% | Mar 21, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $300 → $338 | Buy | Maintains | $300 → $338 | +25.90% | Mar 21, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $275 → $287 | Hold | Maintains | $275 → $287 | +6.91% | Mar 21, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $302 → $325 | Strong Buy | Maintains | $302 → $325 | +21.06% | Mar 21, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $300 | Strong Buy | Maintains | $300 | +11.75% | Mar 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +19.20% | Mar 21, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $272 → $280 | Hold | Maintains | $272 → $280 | +4.30% | Mar 11, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $310 | Buy | Reiterates | $310 | +15.47% | Feb 26, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $300 | Strong Buy | Maintains | $300 | +11.75% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +19.20% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 → $500 | Strong Buy | Reiterates | $400 → $500 | +86.25% | Feb 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $400 → $500 | Strong Buy | Maintains | $400 → $500 | +86.25% | Feb 24, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $384 → $385 | Strong Buy | Maintains | $384 → $385 | +43.41% | Feb 18, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.